Reg Iα, also known as Regenerating islet-derived protein 1 alpha, stands as a vital player in maintaining tissue homeostasis and facilitating repair processes within the body. This multifunctional protein exhibits a wide array of cellular functions, with its primary expression localized to pancreatic islet cells. Within this context, Reg Iα serves as a critical regulator of pancreatic regeneration and beta-cell proliferation, ensuring the restoration of functional pancreatic tissue following injury or insult. Beyond the pancreas, its expression extends to various other tissues, including the gastrointestinal tract, where it contributes to mucosal repair and maintenance. Functionally, Reg Iα plays pivotal roles in promoting cell survival, proliferation, and migration, thereby supporting tissue repair and regeneration processes. Its dysregulation has been implicated in several pathological conditions, ranging from cancer to inflammatory diseases, underlining its significance in disease progression and pathogenesis.
The activation of Reg Iα involves a complex interplay of signaling pathways initiated by various chemical activators. These activators engage diverse mechanisms to stimulate Reg Iα expression, often targeting key intracellular signaling molecules and receptors. For instance, compounds like forskolin and dibutyryl-cAMP act by elevating intracellular cAMP levels, thereby activating transcription factors like CREB and promoting Reg Iα transcription. Similarly, agents like PMA and thapsigargin induce activation of protein kinase C (PKC) and stress-activated protein kinases, respectively, leading to downstream activation of signaling pathways such as MAPK, which enhances Reg Iα expression. Additionally, molecules like retinoic acid and angiotensin II exert their effects by binding to specific receptors and initiating downstream signaling cascades that culminate in increased Reg Iα expression. Overall, the diverse mechanisms employed by chemical activators to regulate Reg Iα expression underscore the complexity of its regulatory network and highlight its critical role in tissue repair and regeneration processes.
SEE ALSO...
Items 1 to 10 of 14 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates Reg Iα expression by directly stimulating adenylate cyclase, leading to increased cAMP levels. Elevated cAMP levels induce Reg Iα transcription via activation of CREB, thereby enhancing its expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates Reg Iα expression by directly activating protein kinase C (PKC), leading to downstream activation of the MAPK pathway. This pathway enhances Reg Iα transcription and translation, promoting its expression. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Involved in pancreatic function and regeneration, could indirectly affect pathways associated with Reg Iα. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid activates Reg Iα expression by binding to retinoic acid receptors (RARs), which heterodimerize with RXRs and bind to RAREs in the Reg Iα promoter, enhancing its transcription. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
Angiotensin II activates Reg Iα expression through activation of the MAPK pathway. This pathway enhances Reg Iα transcription and translation, promoting its expression. | ||||||
L-Noradrenaline | 51-41-2 | sc-357366 sc-357366A | 1 g 5 g | $326.00 $485.00 | 3 | |
Norepinephrine activates Reg Iα expression by binding to adrenergic receptors, leading to activation of the MAPK pathway. This pathway enhances Reg Iα transcription and translation, promoting its expression. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP activates Reg Iα expression by directly elevating intracellular cAMP levels, which activates CREB and promotes Reg Iα transcription. This leads to increased Reg Iα expression. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX activates Reg Iα expression by inhibiting phosphodiesterase (PDE), leading to increased cAMP levels. Elevated cAMP levels induce Reg Iα transcription via activation of CREB, thereby enhancing its expression. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin activates Reg Iα expression by inhibiting sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), leading to intracellular calcium release and activation of the MAPK pathway. This enhances Reg Iα expression. | ||||||
Somatostatin Acetate | 38916-34-6 | sc-220124 | 10 mg | $320.00 | ||
Inhibits growth hormone release; its role in pancreatic function might influence Reg Iα activity. | ||||||